Tanzania Medical Journal

Log in or Register to get access to full text downloads.

Remember me or Register

DOWNLOAD FULL TEXT Open Access  DOWNLOAD FULL TEXT Subscription or Fee Access

The magnitude of intentional non-adherence to antiretroviral therapy among patients attending HIV care and treatment clinic at Muhimbili National Hospital, Dar es Salaam, Tanzania

A Kamuhabwa, M Bakari


Background: Suppression of viral replication is the goal of antiretroviral therapy. It is one of the most important factors influencing long-term prognosis of HIV infection. Non-adherence increases the risk of viral mutations which can result in crossresistance and thus the risk for therapy failure. Objectives: To determine the magnitude of intentional nonadherence to antiretroviral therapy among patients receiving antiretroviral therapy comprised of two nucleoside reverse transcriptase inhibitors and one non-nucleoside reverse transcriptase inhibitor at the HIV care and treatment clinic (CTC) of Muhimbili National Hospital (MNH) in Dar es Salaam, Tanzania. Method: A total of 250 patients were recruited between July 2007 and January 2008 at the HIV CTC of MNH. A structured questionnaire was used for interviewing the patients in order to assess intentional non-adherence through recall, as well as the presence of solicited antiretroviral drugs (ARVs) related side effects during the past 3, 7 and 30 days respectively, since ARV initiation. In addition, clinical (weight changes and incident opportunistic illnesses) as well as immunological (CD4 count) progress in the past 2 years was ascertained through review of patients’ clinical documents. Results: About half (45.6%) of the patients reported to have experienced the side effects associated with ARVs. Most patients (70.1%) experienced peripheral neuropathy. Other side effects
reported included; skin itching/rashes (19.6%), breast enlargement (10.3%), abdominal pain (7.5%), dizziness (5.6%), lipodystrophy (4.7%), vomiting (3.7%), poor vision (2.8%), nausea (1.9%), and headache (1.9%). A total of 18 (7.2 %) patients reported to have ever missed taking their medications. Four patients (1.6%) reported to have skipped their medication in the past 3 days; two (0.8%) in the past 7 days; and twelve (4.8%) in the past 30 days. Only 3 (1.2%) patients admitted to have intentionally skipped their doses due to the side effects they experienced while taking ARVs. The median CD4 count and mean body weight increased from 206 cells/μL and 62 kg to 311 cells/ μL and 65 kg, respectively, during a period of previous 24 months. Conclusion: ARV related side effects were common among patients attending the MNH CTC, but these did not result into significant intentional non-adherence. It is however recommended that a more comprehensive study involving a larger number of patients at different ART providing sites in the country be conducted so as to make a more comprehensive conclusion on this subject. Studies involving self-reported adherence and plasma ARVs concentration measurement area are also necessary in order to make a good correlation of adherence self-reporting and the actual amount of the

drug in the blood.

Key words:
Intentional non-adherence, ARVs, CD4, Weight change, HIV, Antiretroviral therapy
AJOL African Journals Online